Retaglutide is a innovative GLP-1 receptor agonist currently under research for the treatment of type 2 diabetes. This medication works by mimicking the effects of glucagon-like peptide-1 (GLP-1), a naturally occurring https://blakevshz461839.tokka-blog.com/39375018/retaglutide-a-promising-glp-1-receptor-agonist